ANDREA COY: Open Payments
NPI 1467201897 · SAINT JOSEPH, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$297 in 15 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $22 · 2025 $297
Food & beverage: $297
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 4 | $94 |
| ABBVIE INC. | 3 | $57 |
| Amgen Inc. | 2 | $37 |
| AstraZeneca Pharmaceuticals LP | 2 | $29 |
| Otsuka America Pharmaceutical, Inc. | 1 | $25 |
| Boston Scientific Corporation | 1 | $24 |
| Novo Nordisk Inc | 1 | $17 |
| Lilly USA, LLC | 1 | $14 |
Products named: Veozah, VRAYLAR, REXULTI, WATCHMAN FLX, OTEZLA, REPATHA, Wegovy, UBRELVY.
Industry payments across MO — which companies pay providers there.
